Published in N Engl J Med on March 24, 1988
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab (2007) 2.26
Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ Health Perspect (1998) 1.07
Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy. Surg Today (2006) 0.93
Preoperative subclinical hyperthyroidism in patients with papillary thyroid carcinoma. Clin Exp Otorhinolaryngol (2014) 0.83
Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature. Front Mol Biosci (2014) 0.83
Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases. ISRN Endocrinol (2013) 0.82
Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves' disease. J Korean Med Sci (2008) 0.75
Thyroid cancer in Plummer's disease. BMJ Case Rep (2013) 0.75
Thyroid Follicular Carcinoma in a Fourteen-year-old Girl with Graves' Disease. Clin Pediatr Endocrinol (2014) 0.75
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest (1970) 3.64
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol (1999) 3.50
Extra-adrenal pheochromocytoma. J Urol (1992) 3.28
Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med (1992) 3.05
Chronic autoimmune thyroiditis. N Engl J Med (1996) 2.71
American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med (2000) 2.56
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40
A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J Clin Invest (1965) 2.29
Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science (1972) 2.26
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract (2001) 2.15
Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med (1995) 2.10
Risperidone-associated hyperprolactinemia. Endocr Pract (2001) 1.98
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Organ-specific autoimmunity: a 1986 overview. Immunol Rev (1986) 1.84
BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer (2008) 1.83
Overexpression of the RON gene in human breast carcinoma. Oncogene (1998) 1.73
Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. N Engl J Med (1969) 1.70
Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. Oncogene (2011) 1.67
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene (1999) 1.66
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res (1999) 1.63
Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab (1975) 1.62
Iodine-induced thyrotoxicosis in Kivu, Zaire. Lancet (1996) 1.57
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes (1999) 1.56
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest (2002) 1.53
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene (1992) 1.51
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51
Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res (1994) 1.49
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab (1997) 1.44
The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem (1973) 1.43
The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes (2001) 1.42
The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man. J Clin Invest (1970) 1.41
Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care (1989) 1.40
Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway. Diabetologia (1995) 1.39
A cocoon of freshly accelerated cosmic rays detected by Fermi in the Cygnus superbubble. Science (2011) 1.39
Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol Neonate (1986) 1.37
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med (1987) 1.34
Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration. J Clin Endocrinol Metab (1971) 1.34
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. J Clin Invest (1970) 1.34
Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology (1986) 1.33
Growth hormone release during the first year of life in relation to sleep-wake periods. J Clin Endocrinol Metab (1971) 1.32
The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab (1974) 1.32
Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab (1990) 1.31
Insulin receptor expression and function in human breast cancer cell lines. Cancer Res (1992) 1.31
Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med (1983) 1.29
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest (1965) 1.28
The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J Clin Invest (1968) 1.26
The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab (1990) 1.23
Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metab (1998) 1.23
The IGF system in thyroid cancer: new concepts. Mol Pathol (2001) 1.21
Iodide-induced thyrotoxicosis in Boston. N Engl J Med (1972) 1.18
Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents. J Clin Invest (1979) 1.18
The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer (1987) 1.18
Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids (1973) 1.18
The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest (1978) 1.16
Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest (1979) 1.15
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia (2010) 1.14
Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest (1996) 1.13
Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab (1997) 1.13
Abnormal thyroid function and response to iodides in patients with cystic fibrosis. Trans Assoc Am Physicians (1974) 1.13
In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab (1997) 1.13
Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis. N Engl J Med (1982) 1.13
Hereditary adrenocortical unresponsiveness to adrenocorticotropic hormone. J Pediatr (1972) 1.13
Management of emergencies. IX. Thyrotoxic storm. N Engl J Med (1966) 1.12
Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest (1973) 1.12
Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine. J Endocrinol Invest (1982) 1.11
High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) (1989) 1.10
Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease. J Clin Endocrinol Metab (1981) 1.10
Autoregulation of the thyroid. Response to iodide excess and depletion. Mayo Clin Proc (1972) 1.10
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer. Biochimie (1999) 1.09
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes (Lond) (2010) 1.09
Phenformin increases insulin binding to human cultured breast cancer cells. Diabetes (1980) 1.08
Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians (1997) 1.08
Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J Clin Invest (1973) 1.08
Observations concerning the binding of thyroid hormones in sera of normal subjects of varying ages. J Clin Invest (1966) 1.08
Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest (1970) 1.08
Active form of the thyroid hormone. Annu Rev Med (1975) 1.08
Metabolism of L-thyroxine by phagocytosing human leukocytes. J Clin Invest (1973) 1.07
Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science (1983) 1.07
Stimulation of mitochondrial adenosine diphosphate uptake by thyroid hormones. Proc Natl Acad Sci U S A (1973) 1.07